Aims: To compare the angiographic and clinical performance of a paclitaxel-eluting stent using reservoirs technology and a bioabsorbable polymer, without surface coa
1. Heart Centre at the Isar, Munich, Germany; 2. Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands; 3. Vivantes Humboldt-Klinikum, Berlin, Germany; 4. CharitÃ© - Campus Benjamin Franklin, Berlin, Germany; 5. Herz- und Diabeteszentrum NRW, B
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
angioplastytransluminal percutaneous coronarycoronary stenosispaclitaxelstentsdrug-eluting stents
Read next articlePredictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials